The distribution of the pharmacological class of antiplatelets (A) and anticoagulants (B).

<p>N, number of cases; Others, other types of antiplatelets; DOACs, direct oral anticoagulants.</p>

Saved in:

Bibliographic Details
Main Author:	Tsuyoshi Nakai (5880842) (author)
Other Authors:	Takenao Koseki (11965409) (author), Hiroka Nakao (22075874) (author), Koki Kato (2084587) (author), Kazuo Takahashi (182663) (author), Shigeki Yamada (748978) (author), Shoji Matsumoto (1980625) (author)
Published:	2025
Subjects:	Biochemistry Medicine Cell Biology Genetics Pharmacology Cancer Science Policy Space Science Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified ω shrinkage measure type plasminogen activators square statistics models reporting odds ratio randomized controlled trials acute ischemic stroke study may help patients taking antiplatelet significant risk factors prospective observational studies div >< p direct oral anticoagulants also investigated predictors improve clinical outcomes patients taking antiplatelets patients receiving alteplase drug interaction signals study aimed improve symptoms affected patients ich signals warfarin potassium various antiplatelets recombinant tissue ozagrel sodium myocardial infraction intracerebral hemorrhage information components heparin group hemorrhagic transformation eight types diabetes mellitus continued monitoring appropriate use anticoagulant medications alteplase administration aforementioned anticoagulants
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items